All Over Blemish Solution
Natural health product licensed in Canada
- Licence holder
- MD Skincare
- NPN or DIN-HM
- 80006483
- Status
- Active licence
- Licence date
- 8 July 2008
- Revision date
- Not provided
- Form
- Solution
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dimethicone/Vinyltrimethylsiloxysilicate Crosspolymer, Phénoxyéthanol, EDTA de sodium, Ubiquinone, Polymère sequencé de diméthicone, Farnésol, Cyclopentasiloxane, Bisabolol, Polymère croisé de diméthicone/vinyl diméthicone, Mentholum, squalane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Helps treat acne pimples. Penetrates pores to help control (reduce) acne pimples. Helps prevent new acne pimples from forming.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If excessive skin irritation develops or increases, discontinue use and consult a doctor. Avoid contact with eyes; if contact occurs, rinse thoroughly with water. Using other topical acne products at the same time or immediately following use of this product, may increase dryness or irritation of the skin. If this occurs, only one product should be used unless directed by a health care practitioner. If swallowed, get medical help or contact a Poison Control Center right away. For external use only.
Source
Official Health Canada record, licence 80006483
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.